Mercator Medical (FRA:MM2) Cash per Share: €5.19 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MM2 Mercator Medical SA FRA:MM2
63 GF Score
Price €11.32
GF Value €11.46
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Mercator Medical Cash per Share?

Mercator Medical FRA:MM2 +0.89% 63 Cash per Share is €5.19 as of Mar. 2026. GuruFocus rates FRA:MM2 with a GF Score™ of 63/100 and a GF Value™ of €11.46 (Fairly Valued). The stock has 2 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Mercator Medical's Cash per Share for the quarter that ended in Mar. 2026 was €5.19.

Mercator Medical  (FRA:MM2) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Mercator Medical Cash per Share Related Terms

Mercator Medical Cash per Share Historical Data

* Premium members only.

The historical data trend for Mercator Medical's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical Cash per Share Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.72 10.03 8.06 6.26 5.07

Mercator Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.33 4.98 5.17 5.07 5.19
FRA:MM2
63GF Score
Mercator Medical SA FRA:MM2
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Mercator Medical's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=46.365/9.1
=5.07

Mercator Medical's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=47.414/9.1
=5.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of €5.19 mean?
Mercator Medical (FRA:MM2) has a Cash per Share of €5.19 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Mercator Medical and its competitors.
Is Mercator Medical's Cash per Share too high?
Mercator Medical's current Cash per Share is €5.19. Overall, Mercator Medical has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Cash per Share compare to ISRG and BDX?
Mercator Medical's Cash per Share of €5.19 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Medical Devices & Instruments company?
A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Mercator Medical and its competitors. Mercator Medical's current Cash per Share is €5.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Fairly Valued. The stock's GF Value™ is €11.46, compared to a current price of €11.32 — trading 1.2% below its estimated fair value. The current Cash per Share is €5.19. Mercator Medical's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current Cash per Share is €5.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (FRA:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be undervalued. The current stock price of €11.32 is trading 1.2% below its estimated GF Value™ of €11.46. GuruFocus considers Mercator Medical to be Fairly Valued.

Key valuation signals for FRA:MM2:

  • Cash per Share: €5.19
  • GF Value™: €11.46 vs. price of €11.32 (1.2% below fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercator Medical Business Description

Other Exchanges MRC:Poland
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
63GF Score

Get the complete analysis for FRA:MM2

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.32
Price
€11.46
GF Value